KRRO
Korro Bio (KRRO)
$68
About Korro Bio (KRRO)
Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.
Details
Daily high
$9.49
Daily low
$8.66
Price at open
$9.49
52 Week High
$55.89
52 Week Low
$5.20
Market cap
89.5M
Dividend yield
0.00%
Volume
100,279
Avg. volume
198,055
P/E ratio
-1.01
Korro Bio News
Details
Daily high
$9.49
Daily low
$8.66
Price at open
$9.49
52 Week High
$55.89
52 Week Low
$5.20
Market cap
89.5M
Dividend yield
0.00%
Volume
100,279
Avg. volume
198,055
P/E ratio
-1.01